
Patients with connective tissue disease‐associated pulmonary arterial hypertension (CTD‐PAH) have poorer survival and respond less to treatment than those with idiopathic PAH (IPAH). A study compared the metabolomic profiles of CTD-PAH and IPAH patients, finding differences in lipid metabolism. The study findings suggest altered metabolic substrate utilization in CTD-PAH and reduced capacity for mitochondrial beta-oxidation in pulmonary circulation.
Like
Save
Share